1. Home
  2. LMNR vs GALT Comparison

LMNR vs GALT Comparison

Compare LMNR & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$12.68

Market Cap

233.9M

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$2.30

Market Cap

199.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
GALT
Founded
1893
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
199.2M
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
LMNR
GALT
Price
$12.68
$2.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$20.00
$8.50
AVG Volume (30 Days)
52.9K
307.9K
Earning Date
06-08-2026
05-15-2026
Dividend Yield
2.37%
N/A
EPS Growth
N/A
36.84
EPS
N/A
N/A
Revenue
$159,723,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.20
$1.22
52 Week High
$17.11
$7.13

Technical Indicators

Market Signals
Indicator
LMNR
GALT
Relative Strength Index (RSI) 42.28 42.98
Support Level $12.54 $2.18
Resistance Level $14.86 $2.60
Average True Range (ATR) 0.37 0.15
MACD 0.02 0.01
Stochastic Oscillator 28.29 21.52

Price Performance

Historical Comparison
LMNR
GALT

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: